Mov Disord Vol 34, Suppl 2 Archives - Page 15 of 217 - MDS Abstracts

2019 International Congress
Role of Alzheimer’s Disease Genetic Risk Variant rs9331896 in Cognitive Decline in Parkinson’s Disease
T. Tropea, L. Baratta, K. Maddy, M. Guo, J. Rick, V. van Deerlin, J. Trojanowski, D. Weintraub, A. Chen-Plotkin (Philadelphia, PA, USA)
Objective: To investigate whether susceptibility loci for Alzheimer's disease (AD) are associated with rates of longitudinal cognitive decline in Parkinson’s disease (PD). Background: Parkinson’s disease…
2019 International Congress
Dysbiosis of Gut Microbiota in a selected population of Italian Parkinson’s Disease patients
R. Cerroni, D. Pietrucci, M. Conti, V. Unida, A. Farcomeni, M. Pierantozzi, NB. Mercuri, S. Biocca, A. Desideri, A. Stefani (Rome, Italy)
Objective: Our main objective was to investigate dysbiosis of gut microbiota in a selected population of Parkinson’s disease (PD) patients from center-south of Italy, examining…
2019 International Congress
Synchronization Study of Regional Local Field Potential in Rat with Dopamine Receptor Stimulation
SH. Lin, SY. Chen, YY. Chen (Hualien, Taiwan)
Objective: The aim of this study attempts to explore the non-linear interaction with cross-frequency coupling in rats during the stimulation of dopamine receptors. Background: Investigating…
2019 International Congress
Motor compensation in Parkinson’s disease: a multimodal neuroimaging study
N. Villain, N. Pyatigorskaya, S. Lehericy, R. Vallabregue, S. Fernandez-Vidal, MO. Habert, G. Mangone, JC. Corvol, M. Vidailhet, D. Grabli (Paris, France)
Objective: To study motor compensation mechanisms in Parkinson's disease. Background: Whereas akinesia in Parkinson's disease (PD) is linked to dopaminergic neurons death and striatal dopamine depletion,…
2019 International Congress
Frequency and pattern of movement disorders in a Neurologic clinic in North Central Nigeria: a 3- year review
E. Iwuozo, R. Obiako (Makurdi, Nigeria)
Objective: This study evaluated the frequency and pattern of movement disorders in a neurology clinic in a tertiary hospital in North Central Nigeria over a…
2019 International Congress
A Registry for Parkinson’s Disease in Utah
P. Moretti, A. Nakashima, M. Zorn, S. Woltz, L. Farese, L. Cannon-Albright, S. Pulst (Salt Lake City, UT, USA)
Objective: To report the progress made in establishing the Utah Parkinson Disease Registry (UPDR.org). Background: Precise epidemiological information about Parkinson’s disease (PD) and related conditions…
2019 International Congress
LATE ONSET OF PARKINSON’S DISEASE
I. Smolentseva, N. Amosova, A. Kuzmina (Moscow, Russian Federation)
Objective: To study the clinical manifestations of Parkinson's disease with a late onset. Background: Parkinson's disease (PD) is common in the elderly, the average age…
2019 International Congress
Quantitative Susceptibility Mapping: an Biomarker for Diagnosis of Parkinson’s Disease and Evaluation Patients’ Condition
LX. Xue, EH. Xu, JK. Li, Q. Yang, P. Chan (Beijing, China)
Objective: To study deep gray matter susceptibility in Parkinson's Disease (PD) by using quantitative susceptibility mapping (QSM) and to assess the relationship between susceptibility value…
2019 International Congress
The influence of deep brain stimulation on the Parkinson’s disease brain: functional improvement correlates with increased alpha2 and beta band functional connectivity
L. Boon, W. Potters, A. Hillebrand, R. de Bie, M. Bot, R. Schuurman, C. Stam, F. van Rootselaar, H. Berendse (Amsterdam, Netherlands)
Objective: To further unravel the mechanism of action of optimal deep brain stimulation (DBS) treatment effects in Parkinson’s disease (PD), by studying how DBS affects…
2019 International Congress
PPN-GAB-PARK: Short time outcome and long term follow up in PPN-DBS
C. Giordana, M. Borg, JP. Flambart, J. Bredin, D. Fontaine (Nice, France)
Objective: To report the short and long term outcome of bilateral PPN DBS. Background: Deep brain stimulation (DBS) of peducolopontin nucleus (PPN) has been proposed…